Compound Detail
CHEMBL3700337
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL3700337 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | NQFIPWSBOZOBAK-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
0
Publications
0
Known Names
Molecular Properties
377.5
MW (Da)
1.39
ALogP
7
HBA
0
HBD
70.9
PSA (Ų)
0.79
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
Ki 2 meas. best 8.54
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Histamine H3 receptor CHEMBL264 | Ki | 8.54 | 7.95 | 2.9 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Histamine H3 receptor | Ki | = | 2.9 | nM | 8.54 | LANCE Ultra cAMP Assay: The potency of compounds of the invention as H3 receptor... | - |
| Histamine H3 receptor | Ki | = | 44.0 | nM | 7.36 | Radioligand Binding Assay: The affinity of compounds of the invention to the H3 ... | - |
Data from ChEMBL 36 via Core Engine